• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

AND-1是R环动力学的关键调节因子,也是克服内分泌抵抗的一个靶点。

AND-1 is a critical regulator of R-loop dynamics and a target to overcome endocrine resistance.

作者信息

Li Zhuqing, Peng Yihan, Chiang Huai-Chin, Gao Yanjun, Chu Chen, Zhang Yi, Mughal Muhammad Jameel, Liu Chengyu, Li Rong, Pei Huadong, Zhu Wenge

机构信息

Department of Biochemistry and Molecular Medicine, George Washington University School of Medicine and Health Sciences, Washington, DC, USA.

GW Cancer Center, George Washington University, Washington, DC, USA.

出版信息

Sci Adv. 2025 Aug 8;11(32):eadv2453. doi: 10.1126/sciadv.adv2453.

DOI:10.1126/sciadv.adv2453
PMID:40768568
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12327453/
Abstract

R-loops are three-stranded DNA/RNA hybrids that are essential for various cellular pathways. However, when dysregulated, they lead to genomic instability and numerous human diseases. R-loops are tightly regulated, with RNase H1 acting as a key enzyme responsible for resolving DNA/RNA hybrids. Here, we identify the DNA-binding protein AND-1 as an essential factor in R-loop regulation through directly binding to R-loop structures, where it enhances the recruitment of RNase H1 and stimulates its endonuclease activity. We also provide in vivo evidence that R-loop accumulation occurs in the mammary gland tissue of AND-1-deficient mice. Furthermore, we demonstrate that inhibition of AND-1 decreases expression by disrupting R-loop regulation at the enhancer region of the gene in estrogen receptor-positive (ER) breast cancer cells, thereby overcoming resistance to aromatase inhibitors. Collectively, our findings reveal a mechanism by which AND-1 modulates R-loop dynamics and present a promising therapeutic strategy to combat endocrine resistance in breast cancer.

摘要

R环是三链DNA/RNA杂交体,对各种细胞通路至关重要。然而,当失调时,它们会导致基因组不稳定和多种人类疾病。R环受到严格调控,核糖核酸酶H1作为负责分解DNA/RNA杂交体的关键酶。在这里,我们确定DNA结合蛋白AND-1是R环调控的一个重要因素,它通过直接结合R环结构,增强核糖核酸酶H1的募集并刺激其内切核酸酶活性。我们还提供了体内证据,证明在AND-1缺陷小鼠的乳腺组织中发生了R环积累。此外,我们证明抑制AND-1会通过破坏雌激素受体阳性(ER)乳腺癌细胞中该基因增强子区域的R环调控来降低 表达,从而克服对芳香化酶抑制剂的耐药性。总的来说,我们的发现揭示了AND-1调节R环动态的机制,并提出了一种有前景的治疗策略来对抗乳腺癌中的内分泌耐药性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32e9/12327453/a3674dcbeafa/sciadv.adv2453-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32e9/12327453/63ee7b4e00ef/sciadv.adv2453-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32e9/12327453/0939d788546f/sciadv.adv2453-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32e9/12327453/cff6a412013d/sciadv.adv2453-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32e9/12327453/7b3aea25b5e1/sciadv.adv2453-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32e9/12327453/12ad7a97e358/sciadv.adv2453-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32e9/12327453/6bceb14e048d/sciadv.adv2453-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32e9/12327453/a3674dcbeafa/sciadv.adv2453-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32e9/12327453/63ee7b4e00ef/sciadv.adv2453-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32e9/12327453/0939d788546f/sciadv.adv2453-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32e9/12327453/cff6a412013d/sciadv.adv2453-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32e9/12327453/7b3aea25b5e1/sciadv.adv2453-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32e9/12327453/12ad7a97e358/sciadv.adv2453-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32e9/12327453/6bceb14e048d/sciadv.adv2453-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32e9/12327453/a3674dcbeafa/sciadv.adv2453-f7.jpg

相似文献

1
AND-1 is a critical regulator of R-loop dynamics and a target to overcome endocrine resistance.AND-1是R环动力学的关键调节因子,也是克服内分泌抵抗的一个靶点。
Sci Adv. 2025 Aug 8;11(32):eadv2453. doi: 10.1126/sciadv.adv2453.
2
Targeting tumour re-wiring by triple blockade of mTORC1, epidermal growth factor, and oestrogen receptor signalling pathways in endocrine-resistant breast cancer.三重阻断 mTORC1、表皮生长因子和雌激素受体信号通路靶向治疗内分泌耐药乳腺癌的肿瘤重编程。
Breast Cancer Res. 2018 Jun 8;20(1):44. doi: 10.1186/s13058-018-0983-1.
3
PARP-1 as a novel target in endocrine-resistant breast cancer.聚(ADP-核糖)聚合酶-1作为内分泌抵抗性乳腺癌的新靶点。
J Exp Clin Cancer Res. 2025 Jun 16;44(1):175. doi: 10.1186/s13046-025-03441-4.
4
FGFR4 in endocrine resistance: overexpression and estrogen regulation without direct causative role.FGFR4在内分泌抵抗中的作用:过表达与雌激素调节,但无直接因果关系
Breast Cancer Res Treat. 2025 Jun;211(2):501-515. doi: 10.1007/s10549-025-07666-x. Epub 2025 Mar 17.
5
DNMT1 is required for efficient DSB repair and maintenance of replication fork stability, and its loss reverses resistance to PARP inhibitors in cancer cells.高效的DNA双链断裂修复和复制叉稳定性维持需要DNMT1,其缺失会逆转癌细胞对PARP抑制剂的抗性。
Oncogene. 2025 Apr 15. doi: 10.1038/s41388-025-03409-w.
6
First-Line Camizestrant for Emerging -Mutated Advanced Breast Cancer.针对新出现的特定突变晚期乳腺癌的一线用药卡米司他。
N Engl J Med. 2025 Jun 1. doi: 10.1056/NEJMoa2502929.
7
PFKFB3 regulates breast cancer tumorigenesis and Fulvestrant sensitivity by affecting ERα stability.PFKFB3 通过影响 ERα 稳定性调节乳腺癌肿瘤发生和氟维司群敏感性。
Cell Signal. 2024 Jul;119:111184. doi: 10.1016/j.cellsig.2024.111184. Epub 2024 Apr 17.
8
EGR3 and estrone are involved in the tamoxifen resistance and progression of breast cancer.EGR3 和雌酮参与了乳腺癌的他莫昔芬耐药和进展。
J Cancer Res Clin Oncol. 2023 Dec;149(20):18103-18117. doi: 10.1007/s00432-023-05503-6. Epub 2023 Nov 24.
9
RNase H1 and Sen1 ensure that transient TERRA R-loops promote the repair of short telomeres.核糖核酸酶H1(RNase H1)和Sen1确保短暂的端粒重复序列RNA(TERRA)R环促进短端粒的修复。
EMBO Rep. 2025 Jun;26(12):3032-3044. doi: 10.1038/s44319-025-00469-7. Epub 2025 May 22.
10
Imlunestrant a next-generation oral SERD overcomes ESR1 mutant resistance in estrogen receptor-positive breast cancer.Imlunestrant(一种新一代口服选择性雌激素受体降解剂)克服了雌激素受体阳性乳腺癌中的ESR1突变耐药性。
JCI Insight. 2025 May 6. doi: 10.1172/jci.insight.188051.

本文引用的文献

1
R-loop functions in -associated mammary tumorigenesis.R 环在乳腺肿瘤发生中的作用。
Proc Natl Acad Sci U S A. 2024 Aug 13;121(33):e2403600121. doi: 10.1073/pnas.2403600121. Epub 2024 Aug 8.
2
Author Correction: R-loop-derived cytoplasmic RNA-DNA hybrids activate an immune response.作者更正:R环衍生的细胞质RNA-DNA杂交体激活免疫反应。
Nature. 2024 Feb;626(7998):E6. doi: 10.1038/s41586-024-07064-1.
3
R-loops, type I topoisomerases and cancer.R环、I型拓扑异构酶与癌症
NAR Cancer. 2023 Mar 3;5(1):zcad013. doi: 10.1093/narcan/zcad013. eCollection 2023 Mar.
4
Boron Clusters as Enhancers of RNase H Activity in the Smart Strategy of Gene Silencing by Antisense Oligonucleotides.硼簇作为反义寡核苷酸基因沉默智能策略中 RNase H 活性的增强子。
Int J Mol Sci. 2022 Oct 13;23(20):12190. doi: 10.3390/ijms232012190.
5
And-1 Coordinates with the FANCM Complex to Regulate Fanconi Anemia Signaling and Cisplatin Resistance.并且-1 与 FANCM 复合物协同调节范可尼贫血信号和顺铂耐药性。
Cancer Res. 2022 Sep 16;82(18):3249-3262. doi: 10.1158/0008-5472.CAN-22-0769.
6
Walking a tightrope: The complex balancing act of R-loops in genome stability.走钢丝:R 环在基因组稳定性中的复杂平衡作用。
Mol Cell. 2022 Jun 16;82(12):2267-2297. doi: 10.1016/j.molcel.2022.04.014. Epub 2022 May 3.
7
Discovery and characterization of potent And-1 inhibitors for cancer treatment.发现并表征用于癌症治疗的强效 And-1 抑制剂。
Clin Transl Med. 2021 Dec;11(12):e627. doi: 10.1002/ctm2.627.
8
A conserved mechanism for regulating replisome disassembly in eukaryotes.真核生物中调节复制体解体的保守机制。
Nature. 2021 Dec;600(7890):743-747. doi: 10.1038/s41586-021-04145-3. Epub 2021 Oct 26.
9
ESR1 mutations and therapeutic resistance in metastatic breast cancer: progress and remaining challenges.ESR1 突变与转移性乳腺癌的治疗耐药:进展与尚存挑战。
Br J Cancer. 2022 Feb;126(2):174-186. doi: 10.1038/s41416-021-01564-x. Epub 2021 Oct 7.
10
R-loops as Janus-faced modulators of DNA repair.R 环作为 DNA 修复的双面调节因子。
Nat Cell Biol. 2021 Apr;23(4):305-313. doi: 10.1038/s41556-021-00663-4. Epub 2021 Apr 9.